THE ROLE OF NEW & ENABLING TECHNOLOGIES TO DRIVE EUROPEAN CGT COMMERCIALISATION SUCCESS
15:30 – CHAIR INTRODUCTION
Chair: Sven Kili, CEO, Antion Biosciences
15:35 – CASE STUDY: NOVEL SYNBIO APPROACHES FOR A RELIABLE & CONSISTENT SUPPLY OF HUMAN CELLS TO PRECISELY MATCH THE NEEDS OF THE PATIENT & THE DISEASE
Speaker: Mark Kotter, CEO, Bit.Bio
15:50 – CASE STUDY: MOVING BEYOND GENE EDITING FOR EFFICIENT MULTIPLEX CELL ENGINEERING
Speaker: Sven Kili, CEO, Antion Biosciences
16:05 – CASE STUDY: ACCELERATE TIME TO MARKET & INCREASE EFFICIENCY IN MANUFACTURING OPERATIONS
Speaker: Daniel Marroyen, Senior Lifesciences Industry Consultant, Emerson Automation Solutions
16:20 – SHOWCASE
Speaker: Joanna Norman, Senior Staff Scientist VGT, FUJIFILM Diosynth Biotechnologies
16:35 – Q&A SESSION WITH SPEAKERS
Speakers:
Mark Kotter, CEO, Bit.Bio
Daniel Marroyen, Senior Lifesciences Industry Consultant, Emerson Automation Solutions
Joanna Norman, Senior Staff Scientist VGT, FUJIFILM Diosynth Biotechnologies